Bowman and Brooke Logo


February 11, 2014

Michigan Drug Companies Now Less Immune Under Tort Reform

Related Topics
Heart monitor and pill icon - drug and medical device

On January 21, 2014, the U.S. Court of Appeals for the Sixth Circuit ruled that manufacturers and sellers of "combination products"—that is, products which have attributes of both pharmaceuticals and medical devices—are not statutorily immune from liability under Michigan's Tort Reform statute. In an article for Law360, Partners Kim Schmid and Jeffrey Gorcyca discuss the ramifications of the decision.

Read the Law360 article.